State WV
Clinical Trials in West Virginia
West Virginia is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in West Virginia and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 51 actively recruiting studies with West Virginia sites out of 51 registered in total. The busiest research areas in West Virginia are Hypertension, Multiple Myeloma, Migraine. Leading sponsors running trials in the state include West Virginia University, AbbVie, SWOG Cancer Research Network. By stage, West Virginia trials break down as Phase 1 (4), Phase 2 (11), Phase 3 (23), Phase 4 (1).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in West Virginia
Hypertension (2)Multiple Myeloma (2)Migraine (2)Diabetes Mellitus, Type 2 (2)Non-Small Cell Lung Cancer (NSCLC) (1)Circadian Rhythm Disorders (1)Advanced Or Metastatic Merkel Cell Carcinoma (1)Low Grade Astrocytoma (1)Low Grade Glioma (1)Metastatic Low Grade Astrocytoma (1)Metastatic Low Grade Glioma (1)WHO Grade 1 Glioma (1)
Frequently Asked Questions — Clinical Trials in West Virginia
How many clinical trials are currently recruiting in West Virginia?
ClinicalMetric currently tracks 51 actively recruiting clinical trials with at least one location in West Virginia. The total number of registered studies—including active but not currently enrolling trials—is 51. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in West Virginia?
West Virginia hosts clinical trials across a broad range of medical conditions, including Hypertension, Multiple Myeloma, Migraine, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout West Virginia serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in West Virginia?
To join a clinical trial in West Virginia, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in West Virginia maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in West Virginia
NCT07361510 Phase 3
Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participan...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT04578249 N/A
Recruiting
Effects of Blocking Blue Light at Night Post CABG, AVR, MVR, CABG AVR, CABG MVR,...
Condition
Circadian Rhythm Disorders
Enrollment
80 pts
Location
United States
Sponsor
West Virginia University
NCT06947928 Phase 2, Phase 3
Recruiting
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint In...
Condition
Advanced Or Metastatic Merkel Cell Carcinoma
Enrollment
118 pts
Location
United States
Sponsor
TuHURA Biosciences, Inc.
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT07165028 Phase 3
Recruiting
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associ...
Condition
Metabolic Dysfunction-Associated Steatotic Liver Disease
Enrollment
4,500 pts
Location
United States, Argentina, Australia
Sponsor
Eli Lilly and Company
NCT06059638 N/A
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Condition
Hypertension
Enrollment
316 pts
Location
United States, Australia, Belgium
Sponsor
Orchestra BioMed, Inc
NCT03671889 N/A
Recruiting
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's D...
Condition
Alzheimer Disease
Enrollment
50 pts
Location
United States
Sponsor
InSightec
NCT01524276 N/A
Recruiting
Product Surveillance Registry
Condition
Cardiac Rhythm Disorders
Enrollment
100,000 pts
Location
United States, Argentina, Australia
Sponsor
Medtronic
NCT07625189 N/A
Recruiting
EUS-Guided Ablation (RFA and MWA) for Pancreatic and Other Gastrointestinal Lesi...
Condition
RFA
Enrollment
50 pts
Location
United States
Sponsor
West Virginia University
NCT05778188 Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary ...
Condition
Hypoxic-Ischemic Encephalopathy
Enrollment
70 pts
Location
United States
Sponsor
ReAlta Life Sciences, Inc.
NCT06152575 Phase 3
Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in P...
Condition
Multiple Myeloma
Enrollment
492 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
NCT06218875 N/A
Recruiting
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endopros...
Condition
AAA - Abdominal Aortic Aneurysm
Enrollment
2,000 pts
Location
United States, Australia, Austria
Sponsor
W.L.Gore & Associates
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,000 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT05125302 Phase 3
Recruiting
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets f...
Condition
Migraine
Enrollment
1,059 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
NCT05624996 Phase 3
Recruiting
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for...
Condition
Locally Advanced Lung Non-Small Cell Carcinoma
Enrollment
474 pts
Location
United States, Canada
Sponsor
NRG Oncology
NCT04871542 N/A
Recruiting
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Condition
Malignant Solid Neoplasm
Enrollment
2,062 pts
Location
United States, Chile, Guam
Sponsor
SWOG Cancer Research Network
NCT02523014 Phase 2
Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating ...
Condition
Intracranial Meningioma
Enrollment
124 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT06616584 Phase 2, Phase 3
Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Adva...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
378 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT05430035 EARLY_Phase 1
Recruiting
Safety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma
Condition
Gallbladder Adenocarcinoma
Enrollment
10 pts
Location
United States
Sponsor
West Virginia University
NCT06438315 N/A
Recruiting
SuperSaturated Oxygen Comprehensive Observational Registry
Condition
STEMI - ST Elevation Myocardial Infarction
Enrollment
1,000 pts
Location
United States
Sponsor
TherOx
NCT05677490 Phase 3
Recruiting
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanc...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
382 pts
Location
United States, Puerto Rico
Sponsor
Alliance for Clinical Trials i
NCT06513156 N/A
Recruiting
Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder an...
Condition
Opioid Use Disorder
Enrollment
304 pts
Location
United States
Sponsor
Elana Rosenthal
NCT04239573 N/A
Recruiting
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Assoc...
Condition
Pancreatic Neoplasm
Enrollment
770 pts
Location
United States, Canada, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT07017634 Phase 3
Recruiting
Efficacy and Safety of Novosis Putty in Transforaminal Lumbar Interbody Fusion f...
Condition
Degenerative Disc Disease
Enrollment
316 pts
Location
United States
Sponsor
CGBio Inc.
NCT05204888 N/A
Recruiting
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Condition
COPD
Enrollment
642 pts
Location
United States, Canada
Sponsor
Temple University
Page 1 of 3 — 51 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology